Uncertainty over LabCyte’s inclusion in OECD guidelines and its revenue impact

The risk that the inclusion of LabCyte (corneal model) in OECD testing guidelines may be delayed and that the expected revenue impact may not be achieved even after inclusion. This concerns uncertainty over market adoption and monetisation through inclusion in international guidelines, rather than obtaining regulatory approval.